13F HOLDINGS REPORT
Pfizer Inc
Quarter ended Q4 2025 · Filed February 12, 2026 · Accession 0000078003-26-000013
Total Value
$236.5M
Positions
21
Other Managers
0
Confidential Omitted
No
Holdings (21)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ORIC PHARMACEUTICALS INC | ORIC | 5,376,344 | $44.0M | 18.60% |
| 2 | ARVINAS INC | ARVN | 3,457,815 | $41.0M | 17.34% |
| 3 | CELCUITY INC | CELC | 349,406 | $34.8M | 14.74% |
| 4 | WAVE LIFE SCIENCES LTD | WVE | 1,875,000 | $31.9M | 13.48% |
| 5 | ALLOGENE THERAPEUTICS INC | ALLO | 22,032,040 | $30.2M | 12.76% |
| 6 | ZURA BIO LTD | ZURA | 2,970,022 | $15.6M | 6.58% |
| 7 | CARIBOU BIOSCIENCES INC | CRBU | 4,690,431 | $7.5M | 3.15% |
| 8 | PYXIS ONCOLOGY INC | PYXS | 5,952,263 | $6.8M | 2.89% |
| 9 | CARDIFF ONCOLOGY INC | CRDF | 2,411,575 | $6.8M | 2.87% |
| 10 | BIOHAVEN LTD | BHVN | 505,645 | $5.7M | 2.41% |
| 11 | SPERO THERAPEUTICS INC | SPRO | 2,362,348 | $5.5M | 2.33% |
| 12 | NEXTCURE INC | NXTC | 131,109 | $1.9M | 0.79% |
| 13 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 953,834 | $1.3M | 0.54% |
| 14 | PYXIS ONCOLOGY INC | PYXS | 1,080,507 | $1.2M | 0.53% |
| 15 | Q32 BIO INC | QTTB | 277,777 | $922,220 | 0.39% |
| 16 | AN2 THERAPEUTICS INC | ANTX | 715,295 | $815,436 | 0.34% |
| 17 | NEXTCURE INC | NXTC | 26,537 | $376,560 | 0.16% |
| 18 | BOLT BIOTHERAPEUTICS INC | BOLT | 31,305 | $171,176 | 0.07% |
| 19 | GINKGO BIOWORKS HOLDINGS INC | DNABW | 2,681 | $22,279 | 0.01% |
| 20 | SENSEONICS HLDGS INC | SENS | 2,171 | $11,983 | 0.01% |
| 21 | GINKGO BIOWORKS HOLDINGS INC | DNABW | 247 | $2,053 | 0.00% |